Trial Profile
Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 12 Jun 2019
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Arthritis; Osteoarthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors K-STEMCELL
- 12 Feb 2013 New trial record